+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Extracorporeal Membrane Oxygenation Machine Market (2021-2026) by Components, Modality, Application, Patient Type, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 187 Pages
  • November 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5515487
The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be USD 324.67 Mn in 2021 and is expected to reach USD 492.48 Mn by 2026, growing at a CAGR of 8.69%.



Market Dynamics

The rising number of acute respiratory distress syndrome (ARDS) and cardiac failure followed by increasing dependence on a life support machine during an organ failure has created a demand for Extracorporeal Membrane Oxygenation Machines (ECMO), thereby driving the market growth. Also, the growing requirement of ECMO machines during pre and post surgeries in hospitals facilitates market growth.

However, high costs and complexities such as bleeding, infections, etc., are likely to restrain the market growth. Major market players are investing in developing smart ECOM modules, which is anticipated to create opportunities for the market during the forecast period.

Market Segmentation

The Global Extracorporeal Membrane Oxygenation Machine Market is segmented further based on Components, Modality, Application, Patient Type, End-User, and Geography.

By Components, the market is classified as Pumps, Oxygenators, Controllers, Cannula, and Accessories. Amongst all, the Oxygenators segment is expected to hold a major share.

By Modality, the market is classified as Veno-Arterial, Veno-Venous, and Arterio-Venous. Amongst all, the Veno-Arterial segment is expected to hold a major share.

By Application, the market is classified as Respiratory, Cardiac, and ECPR. Amongst all, the Respiratory segment is expected to hold the major share.

By Patient Type, the market is classified as Neonates, Pediatric, and Adult. Amongst all, the Adult segment accounted for the largest share.

By End User, the market is classified as Hospitals, Home Care Settings, Ambulatory Centers, and Others. Amongst all, the Hospital segment holds the highest market share.

By Geography, North America is projected to lead the market.

Recent Developments

1. Liva Nova PLC has stated that its cardiopulmonary products are now being permitted in the U.S. for Extracorporeal Membrane Oxygenation (ECMO) therapy by the USFDA for greater than six hours. - 22nd April 2020
2. Terumo Cardiovascular and CytoSorbents Corporation have formed a collaboration to exclusively sell CytoSorb therapy along with Terumo ECMO machines in ten COVID-19 hotspot states in the U.S.. - 24th August 2020

Company Profiles

Some of the companies covered in the report are Abbott Laboratories, Alung Technologies, MicroPort Scientific Corporation, Nipro Corporation, OriGen Biomedical, Terumo Corporation etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Extracorporeal Membrane Oxygenation Machine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Extracorporeal Membrane Oxygenation Machine Market

What is the estimated value of the Global Extracorporeal Membrane Oxygenation Machine Market?

The Global Extracorporeal Membrane Oxygenation Machine Market was estimated to be valued at $324.67 Million in 2021.

What is the growth rate of the Global Extracorporeal Membrane Oxygenation Machine Market?

The growth rate of the Global Extracorporeal Membrane Oxygenation Machine Market is 8.7%, with an estimated value of $492.49 Million by 2026.

What is the forecasted size of the Global Extracorporeal Membrane Oxygenation Machine Market?

The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be worth $492.49 Million by 2026.

Who are the key companies in the Global Extracorporeal Membrane Oxygenation Machine Market?

Key companies in the Global Extracorporeal Membrane Oxygenation Machine Market include Abbott Laboratories, ALung Technologies, Abiomed, Braille Biomedical, Edwards Lifesciences Corp, Elsius Biomedical Inc., Eurosets Srl, Getinge Group and Medtronic Inc.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Rising Number of Acute Respiratory and Cardiac Failure
4.1.2 Higher Need of a Life Support Machine Due to the Poor Functioning of Body Organs
4.1.3 Growing Requirement During Critical Pre and Post Surgeries in Hospitals
4.2 Restraints
4.2.1 High Cost
4.2.2 Complex and High-Risk Therapy
4.3 Opportunities
4.3.1 Miniaturization of ECMO Machines
4.3.2 Technological Advancement in ECMO Machines
4.4 Challenges
4.4.1 Device Failure and Recall
4.4.2 Lack Skilled Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality
6.1 Introduction
6.2 Veno-Venous ECMO
6.3 Veno-Arterial ECMO
6.4 Arterio-Venous ECMO
7 Global Extracorporeal Membrane Oxygenation Machine Market, By Components
7.1 Introduction
7.2 Pumps
7.2.1 Roller Pumps
7.2.2 Centrifugal Pumps
7.3 Oxygenator
7.4 Controllers
7.5 Cannula
7.6 Accessories
8 Global Extracorporeal Membrane Oxygenation Machine Market, By Application
8.1 Introduction
8.2 Respiratory Applications
8.2.1 Neonates
8.2.2 Pediatrics
8.2.3 Adults
8.3 Cardiac Applications
8.3.1 Adults
8.3.2 Pediatrics
8.3.3 Neonates
8.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
8.4.1 Neonates
8.4.2 Pediatrics
8.4.3 Adults
9 Global Extracorporeal Membrane Oxygenation Machine Market, By Patient Type
9.1 Introduction
9.2 Neonates
9.3 Pediatric
9.4 Adult
10 Global Extracorporeal Membrane Oxygenation Machine Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Home Care Settings
10.4 Ambulatory Centers
10.5 Others
11 Global Extracorporeal Membrane Oxygenation Machine Market, By Geography
11.1 Introduction
11.2 America
11.2.1 Argentina
11.2.2 Brazil
11.2.3 Canada
11.2.4 Chile
11.2.5 Colombia
11.2.6 Mexico
11.2.7 Peru
11.2.8 United States
11.2.9 Rest of Americas
11.3 Europe
11.3.1 Austria
11.3.2 Belgium
11.3.3 Denmark
11.3.4 Finland
11.3.5 France
11.3.6 Germany
11.3.7 Italy
11.3.8 Netherlands
11.3.9 Norway
11.3.10 Poland
11.3.11 Russia
11.3.12 Spain
11.3.13 Sweden
11.3.14 Switzerland
11.3.15 United Kingdom
11.3.16 Rest of Europe
11.4 Middle East and Africa
11.4.1 Egypt
11.4.2 Israel
11.4.3 Qatar
11.4.4 Saudi Arabia
11.4.5 South Africa
11.4.6 United Arab Emirates
11.4.7 Rest of MEA
11.5 Asia-Pacific
11.5.1 Australia
11.5.2 Bangladesh
11.5.3 China
11.5.4 India
11.5.5 Indonesia
11.5.6 Japan
11.5.7 Malaysia
11.5.8 Philippines
11.5.9 Singapore
11.5.10 South Korea
11.5.11 Sri Lanka
11.5.12 Thailand
11.5.13 Taiwan
11.5.14 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 ALung Technologies
13.3 Abiomed
13.4 Braille Biomedical
13.5 Edwards Lifesciences Corp
13.6 Elsius Biomedical Inc.
13.7 Eurosets Srl
13.8 Getinge Group
13.9 LivaNova PLC
13.10 Medtronic Inc
13.11 MicroPort Scientific Corporation
13.12 Nipro Corporation
13.13 OriGen Biomedical
13.14 Spectrum Medical
13.15 Terumo Corporation
13.16 Xenios AG
13.17 Chalice Medical Ltd
13.18 MC3, Inc
13.19 Hemovent GmbH
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • ALung Technologies
  • Abiomed
  • Braille Biomedical
  • Edwards Lifesciences Corp
  • Elsius Biomedical Inc.
  • Eurosets Srl
  • Getinge Group
  • LivaNova PLC
  • Medtronic Inc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OriGen Biomedical
  • Spectrum Medical
  • Terumo Corporation
  • Xenios AG
  • Chalice Medical Ltd
  • MC3, Inc
  • Hemovent GmbH